Testing Status of 2',3'-Dideoxyinosine (AIDS Initiative) M88291
CASRN: 69655-05-6
Related: 124516-24-1
Formula: C10-H12-N4-O3
Synonyms/Common Names
- DDI (AIDS Initiative)
- Inosine, 2',3'-dideoxy-
Special Studies
- Toxicokinetic Study (Gavage; Intravenous)
(K88074)
Completed
- Male Mice: B6C3F1
- Dose: 50 or 250 mg/kg. 500, 1000, or 2000 mg/kg.
Genetic Toxicology
- In Vitro Cytogenetics (CA/SCE)
(705410)
Completed
- Sister Chromatid Exchange Positive
- Chromosome Aberrations Negative
- Micronucleus
(865388)
Completed
- Citation: Phillips, M.D., Nascimbeni, B., Tice, R.R., and Shelby, M.D. Induction of MN in Mouse BM cells: An evaluation of nucleoside analogues used in the treatment of Aids. Environ. Molec. Mutag. Vol. 18 (1991) 168-183
- Mice: B6C3F1
- Male Negative
- Micronucleus
(A08622)
Completed
- Citation: Witt KL, Tice RR, Wolfe GW, Bishop JB. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. Environ Mol Mutagen. 2004;44(4):321-8.
- Mice: Swiss CD-1
- Male Negative
- Micronucleus
(A20001)
Completed
- Citation: Witt KL, Tice RR, Wolfe GW, Bishop JB. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. Environ Mol Mutagen. 2004;44(4):321-8.
- Mice: Swiss CD-1
- Female Negative
- Micronucleus
(A90144)
Completed
- Citation: Witt KL, Tice RR, Wolfe GW, Bishop JB. Genetic damage detected in CD-1 mouse pups exposed perinatally to 3'-azido-3'-deoxythymidine or dideoxyinosine via maternal dosing, nursing, and direct gavage: II. Effects of the individual agents compared to combination treatment. Environ Mol Mutagen. 2004;44(4):321-8.
- Mice: Swiss CD-1
- Male Negative
- Salmonella
(783382)
Completed
- Weakly Positive
Organ Systems Toxicity
- 6 month Immunotoxicity (Gavage)
(IMM94006)
Completed
- Female Mice: B6C3F1
- Dose: 0, 100, 250, 500, OR 1000 MG/KG/DAY.
- 14 or 28 days Immunotoxicity (Gavage)
(IMM96001)
Completed
- Female Mice: B6C3F1
- Dose: +, 0, 100, 250, 500, 1000 MG/KG/DAY.
- 180 days Immunotoxicity (Gavage)
(IMM96004)
Completed
- Female Mice: B6C3F1
- Dose: 0, 100, 250, OR 500 MG/KG TWICE DAILY.
- Repro/Dev Gen Tox (28-Day) (Gavage)
(RDGT92126)
Completed
- Male and Female Mice: CD-1
- Dose: N/A; 0, 500, 1000, 2000 MG/KG; N/A; N/A.